Beta Bionics Q4 Earnings Call Highlights

For the fourth quarter, Beta Bionics reported $32.1 million in net sales , up 57% year-over-year. Saint attributed the growth to:Beta Bionics also emphasized its strategy to expand access through pharmacy reimbursement. Saint said the percentage of new patient starts through pharmacy rose to the high 20s% for full-year 2025, compared with a high single-digit percentage in the prior year, and noted the company has established formulary agreements with all major U.S. pharmacy benefit managers (PBMs).Saint sai ...